Medical Narration
Description
Vocal Characteristics
Language
EnglishVoice Age
Middle Aged (35-54)Accents
North American (Canadian-General) North American (General) North American (US General American - GenAM)Transcript
Note: Transcripts are generated using speech recognition software and may contain errors.
Charles River has developed proprietary H E K 293 and H E K 293 T adherent and suspension cell lines optimized for high productivity, robustness and scalable transient transfection. Our cell lines are fully characterized with a well documented history of vector production for clinical use and are available for clients to use in their production process. Our suspension cell lines are cultured in animal component free conditions. We can further enhance productivity and accelerate timelines for our clients by combining the use of our optimized cell line technology with our off the shelf packaging plasmids and custom E X P DNA plasmid platform process. Our comprehensive development platform follows a proven predictable strategy to derisk your path to GMP. Our team of specialists have deep experience optimizing upstream and downstream processes through small scale shake flask studies to 50 liter bio reactors for a diverse range of viral vectors and serotypes. Our industry leading analytical development expertise allows us to provide a tailored approach, developing and appropriately qualifying product specific essays to support GP readiness for each unique client program without extending delivery timelines. We also have a standard in house testing panel that measures key parameters to ensure product quality will meet regulatory expectations for clients. Working with AAV VECTORS. We have an established N A aviation suspension vector platform process for a, a production capable of cutting vector gene therapy program timelines to GP by up to 55% compared to traditional timelines.